Document:

Voting Agreement and Proxy, dated January 9, 2004

 Exhibit 10.16 
  
 VOTING AGREEMENT AND PROXY 
  
 VOTING AGREEMENT AND PROXY (this “AGREEMENT”), dated as of January 9, 2004, among Daniel Montano, as chairman of COMPANY as hereinafter defined
(“CHAIRMAN”), Cardio Korea Co. LTD (the “STOCKHOLDER”), and Cardio Vascular Genetic Engineering, Inc., a Delaware corporation (the “COMPANY”). 
  
 W I T N E S S E T H: 
  
 WHEREAS, the STOCKHOLDER believes that it is in its best interest to support management and all decisions of management related to the COMPANY;

  
 WHEREAS, the STOCKHOLDER beneficially owns 87,500 shares of
common stock (the “SHARES”) of COMPANY; 
  
 WHEREAS,
COMPANY has requested that the STOCKHOLDER agree, and the STOCKHOLDER has agreed, to vote, or execute a written consent in respect of, all the SHARES, together with any shares acquired after the date of this Agreement, whether upon the exercise of
options, conversion of convertible securities or otherwise, and any other voting securities of the COMPANY (whether acquired heretofore or hereafter) that are beneficially owned by the STOCKHOLDER or over which the STOCKHOLDER has, directly
or indirectly, the right to vote (collectively, the “VOTING SHARES”), in favor of any matters recommended by the board of directors of the COMPANY and submitted to the STOCKHOLDER. 
  
 NOW, THEREFORE, in consideration of the sum of $100.00, the within premises
and for other good and valuable consideration given to each party hereto, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
  

	1.	AGREEMENT TO VOTE AND PROXY. 

  
 1.1. AGREEMENT TO VOTE. The Stockholder hereby agrees that, during the time this Agreement is in effect, at any meeting of the stockholders of the
Company, however called, or any adjournment thereof, or by written consent, the Stockholder shall be present (in person or by proxy) and vote (or cause to be voted), or execute a written consent in respect of, all of its Voting Shares in favor of
any matter that is recommended by board of directors of the Company. 
  

	 	1.2.	PROXY. 

  
 (a) The Stockholder hereby appoints the Chairman, until termination of this Agreement, as such Stockholder’s attorney and proxy with full power of substitution, to vote, and otherwise act (by written consent or
otherwise) with respect to the Voting Shares of such Stockholder, on the matters and in the manner specified in Section 1.1 hereof. 
  
 (b) The Stockholder hereby revokes all other proxies and powers of attorney on the matters specified in Section 1.1 or to the extent inconsistent with the
matters set forth in Section 1.1 with respect to the Voting Shares which the Stockholder may have heretofore 

 
appointed or granted, and no subsequent proxy or power of attorney shall be given or written consent executed (and if given or executed, shall not be
effective) by the Stockholder with respect thereto. All authority herein conferred or agreed to be conferred shall survive the bankruptcy, dissolution or liquidation of the Stockholder and any obligation of the Stockholder under this Agreement shall
be binding upon the successors of the Stockholder. 
  

	2.	TERM AND TERMINATION. 

  
 2.1. TERM OF THIS AGREEMENT. The term (“Term”) of this Agreement shall commence on the date hereof and shall terminate on the earlier of (a) 30
days following the effective date of a Registration Statement filed by Company with the Securities and Exchange Commission relating to an initial public offering of the Company’s securities, or (b) one year from the date of this Agreement.

  
 2.2. EFFECT OF TERMINATION. Upon the expiration of this
Agreement pursuant to Section 2.1, this Agreement shall become void and of no effect with no liability on the part of any party hereto, provided that no such termination shall relieve any party hereto from any liability for any breach of this
Agreement occurring prior to such termination. 
  

	3.	REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER. The Stockholder hereby represents and warrants to COMPANY: 

  
 3.1. DUE ORGANIZATION. The Stockholder represents and warrants that it has
been duly organized, is validly existing and is in good standing, as applicable, under the laws of the jurisdiction of its organization. 
  
 3.2. POWER; DUE AUTHORIZATION; BINDING AGREEMENT. The Stockholder has full legal capacity, power and authority to execute and deliver this Agreement and
proxy, to perform its obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder and constitutes a valid and binding agreement of such Stockholder,
enforceable against such Stockholder in accordance with its terms, except that enforceability may be subject to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium or other similar laws affecting or relating to the
enforcement of creditors rights generally and to general principles of equity. 
  
 3.3. OWNERSHIP OF SHARES. On the date hereof, the Shares are owned of record or beneficially by the Stockholder and constitute all of the Voting Shares owned of record or beneficially by the Stockholder, free and
clear of any claims, liens, encumbrances. As of the date hereof the Stockholder has, and as of the date of any stockholder meeting (or action by written consent), the Stockholder will have sole voting power and sole dispositive power with respect to
all of the Shares of the Stockholder. 
  
 3.4. NO CONFLICTS. The
execution and delivery of this Agreement by the Stockholder does not, and the performance of the terms of this Agreement by the Stockholder will not, (a) require the Stockholder to obtain the consent or approval of, or make any filing with or
notification to, any governmental or regulatory authority, domestic or foreign, (b) require the 

  

 2 

 
consent or approval of any other person pursuant to any material agreement, obligation or instrument binding on the Stockholder or its properties and assets,
(c) conflict with or violate any organizational document or law, rule, regulation, order, judgment or decree applicable to the Stockholder or by which any property or asset of such Stockholder is bound or (d) violate any other agreement to which the
Stockholder is a party including, without limitation, any voting agreement, stockholders agreement, irrevocable proxy or voting trust, except for any consent, approval, filing or notification which has been obtained as of the date hereof or the
failure of which to obtain, make or give would not, or any conflict or violation which would not, prevent, delay or materially adversely affect the consummation of the transactions contemplated by this Agreement. 
  

	4.	CERTAIN COVENANTS OF STOCKHOLDERS. The Stockholder hereby covenants and agrees (solely as to such Stockholder) as follows: 

  
 4.1. RESTRICTION ON TRANSFER, PROXIES AND NON-INTERFERENCE. 
  
 (a) Except as set forth in Section 4.1(b), the Stockholder hereby agrees,
while this Agreement is in effect, and except as contemplated hereby, not to (i) sell, transfer, pledge, encumber, assign or otherwise dispose of, or enter into any contract, option or other arrangement or understanding with respect to the sale,
transfer, pledge, encumbrance, assignment or other disposition of, or limitation on the voting rights of, any of the Voting Shares, (ii) grant any proxies or powers of attorney other than that which may arise pursuant to Section 1.2, deposit any
Voting Shares into a voting trust or enter into a voting agreement with respect to any Voting Shares, (iii) take any action that would cause any representation or warranty of such Stockholder contained herein to become untrue or incorrect or have
the effect of preventing or disabling such Stockholder from performing its obligations under this Agreement or (iv) commit or agree to take any of the foregoing actions. Any transfer of Voting Shares not permitted hereby shall be null and void. The
Stockholder agrees that any such prohibited transfer may and should be enjoined if any involuntary transfer of any of the Voting Shares shall occur (including, but not limited to, a sale by a Stockholder’s trustee in bankruptcy, or a sale to a
purchaser at any creditor’s or court sale), the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Voting Shares subject to all of the
restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect. 
  
 (b) This Agreement shall not restrict the Stockholder from (i) using Voting Shares as collateral or a pledge for borrowings from a financial institution,
provided such financial institution agrees in writing with the Company to be bound by all of the terms hereof; or (ii) transferring Voting Shares to other entities controlled by such Stockholder, or in connection with tax or financial planning,
provided that any such transferee agrees in writing with the Company to be bound by all of the terms of this Agreement. 
  
 4.2. ADDITIONAL SHARES. During the Term of this Agreement, the Stockholder hereby agrees, to promptly notify Company of the number of any new Voting
Shares acquired by such Stockholder, if any. Any such shares shall be subject to the terms of this Agreement. 
  

 3 

	5.	FURTHER ASSURANCES. From time to time, at Company’s request and without further consideration, the Stockholder shall execute and deliver such additional documents and take all
such further action as may be necessary or desirable to consummate and make effective the transactions contemplated by Section 1 and Section 2 of this Agreement. 

  

	6.	STOP TRANSFER ORDER. In furtherance of this Agreement, and concurrently herewith, the Stockholder shall and hereby does authorize the Company or the Company’s counsel to notify
the Company’s transfer agent that there is a stop transfer order with respect to all of such Stockholder’s Voting Shares. 

  

	7.	MISCELLANEOUS. 

  
 7.1. NON-SURVIVAL. The representations and warranties made herein shall not survive the termination of this Agreement. 
  
 7.2. ENTIRE AGREEMENT; ASSIGNMENT; LIMITED THIRD PARTY BENEFICIARIES. This
Agreement (i) constitutes the entire agreement among the parties with respect to the subject matter hereof and supersedes all other prior agreements and understandings, both written and oral, among the parties with respect to the subject matter
hereof, and (ii) shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature
whatsoever under or by reason of this Agreement, except that Company shall be entitled to enforce Section 1.1 hereof against the Stockholder as an intended third-party beneficiary of their obligations thereunder. 
  
 7.3. AMENDMENTS. This Agreement may not be modified, amended, altered or
supplemented, except upon the execution and delivery of a written agreement executed by each of the parties hereto. 
  
 7.4. NOTICES. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to
have been duly received if so given) by hand delivery, by facsimile transmission or by mail (registered or certified mail, postage prepaid, return receipt requested) or by any courier service, such as Federal Express, providing proof of delivery.
All communications hereunder shall be delivered to the respective parties at the following addresses: 
  
 If to the Stockholder: 
  
 Cardio Korea Co. LTD 
 _____________________

  
 _____________________ 
 Attention:     Joong-Ki (President), Baik of the Seoul Angles group 
 Facsimile:    
                     
  

 4 

 If to Company: 
  

			
	 Cardio Vascular Genetic Engineering, Inc.

	 14272 Franklin Avenue, Suite 110

	 Tustin, CA 92780

	 Attention:
	 	 Dan Montano

	 Facsimile:
	 	 (714) 368-1817

	
	 with a copy to:

	
	 Lord Bissell & Brook LLP

	 300 S. Grand Avenue, Suite 800

	 Los Angeles, CA 90071

	 Attention:
	 	 Ronald Warner, Esq.

	 Facsimile:
	 	 (213) 485-1200

  
 or to such other address as the person
to whom notice is given may have previously furnished to the others in writing in the manner set forth above. 
  
 7.5. GOVERNING LAW. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, regardless of the laws that
might otherwise govern under applicable principles of conflicts of laws thereof. 
  
 7.6. REMEDIES. The Stockholder recognizes and acknowledges that a breach by it of any covenants or agreements contained in this Agreement will cause Company to sustain irreparable injury and damages, for which money
damages would not provide an adequate remedy, and therefore the Stockholder agrees that in the event of any such breach Company shall be entitled to the remedy of specific performance of such covenants and agreements and injunctive and other
equitable relief. Notwithstanding any provision of this Agreement to the contrary, or any principle of law or of equity, Company agrees that its sole remedy for breach of this Agreement shall be specific performance by the Stockholder of the terms
of this Agreement, and that in no case shall Company be entitled to monetary or other damages in connection with this Agreement, whether liquidated, special, consequential or punitive or in any other form whatsoever. As a condition to the
Stockholder’s willingness to enter into this Agreement, Company hereby, on its behalf and on that of its affiliates, irrevocably and unconditionally waives any such claim for damages that it may have, whether in law or in equity, in any
jurisdiction and forum whatsoever. 
  
 7.7. COUNTERPARTS. This
Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same Agreement. 
  
 7.8. DESCRIPTIVE HEADINGS. The descriptive headings used herein are inserted for convenience of reference only and are not
intended to be part of or to affect the meaning or interpretation of this Agreement. 
  

 5 

 7.9. SEVERABILITY. Whenever possible, each provision or portion of any provision of this Agreement will
be interpreted in such manner as to be effective and valid under applicable law. In the event any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule
in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or portion of any provision in such jurisdiction, and this Agreement will be reformed, construed and enforced in such jurisdiction as if such
invalid, illegal or unenforceable provision or portion of any provision had never been contained herein. 
  
 [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.] 
  

 6 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and
year first above written. 
  

			
	 CARDIO VASCULAR GENETIC
 ENGINEERING,
INC.

		
	By:	 	 /s/    DAN MONTANO

	Name:	 	Dan Montano
	Title:	 	Chairman
	
	CARDIO KOREA CO. LTD
		
	By:	 	 /s/    JOONG KI

	Name:	 	Joong Ki
	Title:	 	President
		
	 	 	 
	
	DANIEL MONTANO
	
	 /s/    DANIEL MONTANO

 As Chairman of CARDIO VASCULAR
 GENETIC ENGINEERING,
INC

  

 7Exhibit 4.2

     THE  SECURITIES   REPRESENTED  BY  THIS  WARRANT  HAVE  BEEN  ACQUIRED  FOR
     INVESTMENT AND HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933,
     AS AMENDED (THE  "SECURITIES  ACT").  THESE  SECURITIES  MAY NOT BE SOLD OR
     TRANSFERRED IN THE ABSENCE OF SUCH  REGISTRATION OR AN EXEMPTION  THEREFROM
     UNDER THE SECURITIES ACT OR UNDER STATE  SECURITIES  LAWS. THIS WARRANT MAY
     NOT BE SOLD, ASSIGNED, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT
     TO THE  EXPRESS  PROVISIONS  OF  THIS  WARRANT,  AND NO  SALE,  ASSIGNMENT,
     TRANSFER,  OR OTHER DISPOSITION OF THIS WARRANT SHALL BE VALID OR EFFECTIVE
     UNLESS AND UNTIL SUCH PROVISIONS SHALL HAVE BEEN COMPLIED WITH.

                                            Date of Issuance: September 30, 2004

                             NESCO INDUSTRIES, INC.

                             Stock Purchase Warrant

                           (Void after July 15, 2009)

     NESCO  Industries,  Inc., a Nevada  corporation (the "Company"),  for value
received,  hereby certifies and agrees that __________________ or its registered
assigns (the "Registered Holder"),  is entitled,  subject to the terms set forth
below,  to  purchase  from the  Company,  at any time or from time to time on or
after the date hereof (the "Date of  Issuance")  and on or before the earlier to
occur of July 15, 2009 or the fifth (5th) anniversary of the Date of Issuance at
not later  than 5:00 p.m.  New York time (such  date and time,  the  "Expiration
Time"), ___________________  (________________) duly authorized, validly issued,
fully paid and  nonassessable  shares of the Company's common stock,  $0.001 par
value per share (the "Common Stock") at an initial exercise price equal to $0.25
per share,  subject to  adjustment  in certain  cases as described  herein.  The
shares  purchasable  upon exercise of this Warrant,  and the purchase  price per
share,  are  hereinafter  referred to as the "Warrant  Shares" and the "Exercise
Price,"  respectively.  The term  "Warrant"  as used herein  shall  include this
Warrant and any other warrants  delivered in substitution or exchange  therefor,
as provided herein.

     This  Warrant  is  issued  pursuant  to that  certain  Securities  Purchase
Agreement of even date  herewith by and among the Company and certain  investors
set forth therein (the "Securities Purchase Agreement").

     1. Exercise.

          1.1. Method of Exercise

     (a) This Warrant may be exercised by the Registered  Holder, in whole or in
part, by  surrendering  this  Warrant,  with a Notice of Exercise in the form of
Annex A hereto (the  "Notice of  Exercise")  duly  executed  by such  Registered

                                       1
<PAGE>

Holder or by such Registered Holder's duly authorized attorney, at the principal
office of the Company set forth on the signature  page hereto,  or at such other
office or  agency as the  Company  may  designate  in  writing  (the  "Company's
Office"),  accompanied by payment in full, in lawful money of the United States,
of the  Exercise  Price  payable  in  respect of the number of shares of Warrant
Shares purchased upon such exercise.

     (b) Each  exercise of this  Warrant  shall be deemed to have been  effected
immediately  prior to the close of business on the day on which the  appropriate
Annex form shall be dated and  directed  to the  Company  (as  evidenced  by the
applicable  postmark or other  evidence of  transmittal)  as provided in Section
1(a)  hereof.  At such  time,  the  person or persons in whose name or names any
certificates for Warrant Shares shall be issuable upon such exercise as provided
in Section  1(c) hereof  shall be deemed to have become the holder or holders of
record of the Warrant Shares represented by such certificates.

     (c) As soon as practicable  after the exercise of this Warrant,  in full or
in part, and in any event within ten (10) days thereafter,  the Company,  at its
expense,  will  cause to be  issued  in the  name  of,  and  delivered  to,  the
Registered Holder, or as such Registered Holder (upon payment by such Registered
Holder of any applicable transfer taxes) may direct:

     (i) a certificate or certificates  for the number of full Warrant Shares to
which such Registered  Holder shall be entitled upon such exercise plus, in lieu
of any  fractional  share to which such  Registered  Holder  would  otherwise be
entitled, cash in an amount determined pursuant to Section 4 hereof; and

     (ii) in case such  exercise  is in part only,  a new  warrant  or  warrants
(dated the date hereof) of like tenor, representing in the aggregate on the face
or faces thereof the number of Warrant  Shares equal  (without  giving effect to
any  adjustment  therein) to the number of such shares called for on the face of
this Warrant minus the number of such shares purchased by the Registered  Holder
upon such  exercise  as  provided  in Section 3 hereof or  received  pursuant to
Section 1.2 hereof.

     1.2. Exercise by Surrender of Warrant. In addition to the method of payment
set forth in Section 1.1 and in lieu of any cash  payment  required  thereunder,
the Warrant may be exercised by surrendering the Warrant in the manner specified
in this Section 1,  together  with  irrevocable  instructions  to the Company to
issue in exchange  for the Warrant the number of shares of Common Stock equal to
the product of (x) the number of shares of Common Stock  underlying the Warrants
multiplied  by (y) a fraction,  the  numerator  of which is the Market Value (as
defined below) of the Common Stock less the Exercise  Price and the  denominator
of which is such Market Value. As used herein,  the phrase "Market Value" at any
date shall be deemed to be the last  reported  sale  price,  or, in case no such
reported  sale takes place on such day,  the average of the last  reported  sale
prices  for the last  three  (3)  trading  days,  in either  case as  officially
reported by the principal  securities  exchange or "over the counter" (including
on the pink sheets or  bulletin  board)  exchange  on which the Common  Stock is

                                       2
<PAGE>

listed or admitted to trading, or, if the Common Stock is not listed or admitted
to trading on any national securities  exchange or sold "over the counter",  the
average  closing bid price as furnished  by the NASD  through  NASDAQ or similar
organization if NASDAQ is no longer reporting such information, or if the Common
Stock is not quoted on NASDAQ,  as determined in good faith by resolution of the
Board of Directors of the Company,  based on the best  information  available to
it.

     2. Shares to be Fully Paid;  Reservation of Shares.  The Company  covenants
and agrees that all shares of Common Stock which may be issued upon the exercise
of the rights represented by this Warrant will, upon issuance by the Company, be
validly issued,  fully paid and  nonassessable,  and free from preemptive rights
and free from all taxes,  liens and charges  with respect  thereto.  The Company
further  covenants  and agrees  that,  from and after the Date of  Issuance  and
during the period  within  which the rights  represented  by this Warrant may be
exercised, the Company will at all times have authorized, and reserve, free from
preemptive  rights,  out of its authorized but unissued  shares of Common Stock,
solely for the purpose of effecting the exercise of this  Warrant,  a sufficient
number of shares of Common  Stock to  provide  for the  exercise  of the  rights
represented by this Warrant.

     3. Fractional  Shares.  The Company shall not be required upon the exercise
of this Warrant to issue any  fractional  shares,  but shall make an  adjustment
therefor in cash on the basis of the Market Value for each  fractional  share of
the  Company's  Common  Stock  which  would be  issuable  upon  exercise of this
Warrant.

     4. Requirements for Transfer.

     (a) Warrant  Register.  The Company will  maintain a register (the "Warrant
Register")  containing  the  names and  addresses  of the  Registered  Holder or
Registered Holders. Any Registered Holder of this Warrant or any portion thereof
may change its address as shown on the Warrant Register by written notice to the
Company requesting such change, and the Company shall promptly make such change.
Until this Warrant is  transferred on the Warrant  Register of the Company,  the
Company may treat the Registered  Holder as shown on the Warrant Register as the
absolute owner of this Warrant for all purposes,  notwithstanding  any notice to
the  contrary,  provided,  however,  that if and when this  Warrant is  properly
assigned in blank,  the Company may,  but shall not be  obligated  to, treat the
bearer hereof as the absolute owner hereof for all purposes, notwithstanding any
notice to the contrary.

     (b) Warrant  Agent.  The Company may, by written  notice to the  Registered
Holder,  appoint an agent for the purpose of  maintaining  the Warrant  Register
referred to in Section 4(a) hereof,  issuing the Common Stock  issuable upon the
exercise of this Warrant, exchanging this Warrant, replacing this Warrant or any
or all of the foregoing. Thereafter, any such registration,  issuance, exchange,
or replacement, as the case may be, may be made at the office of such agent.

     (c) Transfer. Subject to the provisions of this Section 4, this Warrant and
all rights hereunder are  transferable,  in whole or in part, upon the surrender
of this Warrant with a properly  executed  Assignment Form in substantially  the
form attached hereto as Annex B (the  "Assignment")  at the principal  office of
the Company.

                                       3
<PAGE>

     (d) Exchange of Warrant  Upon a Transfer.  On surrender of this Warrant for
exchange,  properly  endorsed on the Assignment and subject to the provisions of
this Warrant and with the  limitations on assignments and transfers as contained
in this Section 4, the Company at its expense  shall issue to or on the order of
the  Registered  Holder a new warrant or warrants of like tenor,  in the name of
the Registered  Holder or as the Registered Holder (on payment by the Registered
Holder of any applicable  transfer  taxes) may direct,  for the number of shares
issuable upon exercise hereof.

     5. Adjustment.

     (a) Computation of Adjusted Exercise Price. Except as hereinafter provided,
in case the Company  shall at any time after the date  hereof  issue or sell any
shares of its Stock (as defined in Section  5(g)),  other than the  issuances or
sales  referred to in Section 5(h) hereof,  for a  consideration  per share less
than the Exercise Price in effect  immediately  prior to the issuance or sale of
such shares,  or without  consideration,  then  forthwith  upon such issuance or
sale,  the Exercise Price shall (until another such issuance or sale) be reduced
to the price (calculated to the nearest full cent) equal to the quotient derived
by  dividing  (A) an  amount  equal  to the  sum of (X) the  product  of (a) the
Exercise Price in effect immediately prior to such issuance or sale,  multiplied
by (b) the total number of shares of Stock outstanding immediately prior to such
issuance or sale, plus (Y) the aggregate of the amount of all consideration,  if
any, received by the Company upon such issuance or sale, by (B) the total number
of  shares  of  Stock  outstanding  immediately  after  such  issuance  or sale;
provided,  however,  that in no event  shall  the  Exercise  Price  be  adjusted
pursuant to this  computation  to an amount in excess of the  Exercise  Price in
effect  immediately  prior  to  such  computation,  except  in  the  case  of  a
combination of outstanding  shares of Stock, as provided by Section 5(c) hereof.
For the  purposes  of this  Section 5 the term  Exercise  Price  shall  mean the
Exercise  Price  per  share set  forth on the  first  page of this  Warrant,  as
adjusted from time to time pursuant to the provisions of this Section 5.

     (i) For  purposes of any  computation  to be made in  accordance  with this
Section 5(a), the following provisions shall be applicable:

     (ii) In case of the issuance or sale of shares of Stock for a consideration
part or all of which shall be cash, the amount of the cash consideration,  shall
be deemed to be the amount of cash  received by the Company for such shares (or,
if shares of Stock are offered by the Company for subscription, the subscription
price, or, if either of such securities shall be sold to underwriters or dealers
for public  offering  without a subscription  price,  the public offering price,
before  deducting  therefrom any  compensation  paid or discount  allowed in the
sale,  underwriting  or  purchase  thereof by  underwriters  or dealers or other
persons or entities  performing similar  services),  or any expenses incurred in
connection  therewith  and less any amounts  payable to security  holders or any
affiliate thereof,  including,  without  limitation,  any employment  agreement,
royalty,  consulting agreement,  covenant not to compete,  earnout or contingent
payment right or similar arrangement,  agreement or understanding,  whether oral
or written;  all such amounts  shall be valued at the aggregate  amount  payable
thereunder  whether such payments are absolute or contingent and irrespective of
the period or  uncertainty  of  payment,  the rate of  interest,  if any, or the
contingent nature thereof.

                                       4
<PAGE>

     (iii) In case of the  issuance  or sale  (otherwise  than as a dividend  or
other  distribution  on any  stock of the  Company)  of  shares  of Stock  for a
consideration  part or all of which shall be other than cash,  the amount of the
consideration  therefor  other than cash shall be deemed to be the value of such
consideration  as  determined  in good  faith by the Board of  Directors  of the
Company.

     (iv) Shares of Stock issuable by way of dividend or other  distribution  on
any capital stock of the Company shall be deemed to have been issued immediately
after the  opening of  business  on the day  following  the record  date for the
determination  of  stockholders  entitled  to  receive  such  dividend  or other
distribution and shall be deemed to have been issued without consideration.

     (v) The  reclassification of securities of the Company other than shares of
Stock into securities  including  shares of Stock shall be deemed to involve the
issuance of such shares of Stock for  consideration  other than cash immediately
prior to the  close of  business  on the date  fixed  for the  determination  of
security  holders  entitled  to  receive  such  shares,  and  the  value  of the
consideration  allocable to such shares of Stock shall be determined as provided
in Section 5(v).

     (vi) The  number  of  shares  of Stock  at any one time  outstanding  shall
include  the  aggregate  number  of  shares  issued  or  issuable   (subject  to
readjustment  upon  the  actual  issuance  thereof)  upon the  exercise  of then
outstanding  options,   rights,   warrants,  and  convertible  and  exchangeable
securities.

     (b) Options, Rights, Warrants and Convertible and Exchangeable Securities.

     (i) In case the  Company  shall at any time  after  the date  hereof  issue
options,  rights or  warrants  to  subscribe  for shares of Stock,  or issue any
securities  convertible  into  or  exchangeable  for  shares  of  Stock,  for  a
consideration per share less than the Exercise Price in effect immediately prior
to the  issuance  of such  options,  rights,  warrants  or such  convertible  or
exchangeable securities, or without consideration,  the Exercise Price in effect
immediately  prior to the  issuance of such  options,  rights,  warrants or such
convertible or exchangeable securities,  as the case may be, shall be reduced to
a price  determined by making a computation in accordance with the provisions of
Section 5(a) hereof, provided that:

     (ii) The aggregate  maximum number of shares of Stock,  as the case may be,
issuable under such options, rights or warrants shall be deemed to be issued and
outstanding  at the time such  options,  rights or warrants  were issued,  for a
consideration equal to the minimum purchase price per share provided for in such
options,  rights or warrants  at the time of  issuance,  plus the  consideration
(determined in the same manner as consideration received on the issue or sale of
shares in  accordance  with the terms of the Warrant),  if any,  received by the
Company for such options,  rights or warrants.  The aggregate  maximum number of
shares of Stock  issuable  upon  conversion  or exchange of any  convertible  or
exchangeable securities shall be deemed to be issued and outstanding at the time
of  issuance  of  such  securities,   and  for  a  consideration  equal  to  the
consideration  (determined in the same manner as  consideration  received on the
issue or sale of shares of Stock in  accordance  with the terms of the  Warrant)
received by the Company for such securities, plus the minimum consideration,  if

                                       5
<PAGE>

any,  receivable by the Company upon the conversion or exchange thereof.  If any
change  shall occur in the price per share  provided  for in any of the options,
rights or warrants referred to in subsection, or in the price per share at which
the securities  referred to in this subsection are  exchangeable,  such options,
rights or warrants or exchange  rights,  as the case may be,  shall be deemed to
have expired or terminated  on the date when such price change became  effective
in respect to shares not theretofore issued pursuant to the exercise or exchange
thereof,  and the  Company  shall be  deemed to have  issued  upon such date new
options,  rights or  warrants  or  exchangeable  securities  at the new price in
respect of the number of shares  issuable  upon the  exercise  of such  options,
rights  or  warrants  or  the  conversion  or  exchange  of  such   exchangeable
securities.

     (c) Subdivision and Combination.  If the Company at any time subdivides (by
any   stock   split,   stock   dividend,    recapitalization,    reorganization,
reclassification  or  otherwise)  the  shares of Stock  subject  to  acquisition
hereunder  into a greater number of shares,  then,  after the date of record for
effecting such  subdivision,  the Exercise Price in effect  immediately prior to
such  subdivision  will be  proportionately  reduced and the number of shares of
Common  Stock  subject to  acquisition  upon  exercise of this  Warrant  will be
proportionately increased. If the Company at any time combines (by reverse stock
split,  recapitalization,  reorganization,  reclassification  or otherwise)  the
shares of Stock  subject  to  acquisition  hereunder  into a  smaller  number of
shares,  then,  after the date of record for  effecting  such  combination,  the
Exercise  Price  in  effect  immediately  prior  to  such  combination  will  be
proportionately  increased  and the number of shares of Common Stock  subject to
acquisition upon exercise of this Warrant will be proportionately decreased.

     (d) Merger or  Consolidation.  In case of any  consolidation of the Company
with,  or merger of the Company  into any other  corporation,  or in case of any
sale or  conveyance  of all or  substantially  all of the assets of the  Company
other than in  connection  with a plan of complete  liquidation  of the Company,
then  as a  condition  of such  consolidation,  merger  or  sale or  conveyance,
adequate  provision  will be made  whereby the  Registered  Holder will have the
right to acquire and receive upon exercise of this Warrant in lieu of the shares
of Common Stock immediately theretofore subject to acquisition upon the exercise
of this Warrant, such shares of stock,  securities or assets as may be issued or
payable  with respect to or in exchange for the number of shares of Common Stock
immediately  theretofore  subject to acquisition and receivable upon exercise of
this  Warrant had such  consolidation,  merger or sale or  conveyance  not taken
place. In any such case, the Company will make  appropriate  provision to insure
that the  provisions  of this Section 5 hereof will  thereafter be applicable as
nearly as may be in  relation  to any shares of stock or  securities  thereafter
deliverable upon the exercise of this Warrant.

     (e) Notice of  Adjustment.  Upon the occurrence of any event which requires
any  adjustment  of the Exercise  Price,  then and in each such case the Company
shall give notice thereof to the Registered Holder, which notice shall state the
Exercise Price resulting from such  adjustment and the increase or decrease,  if
any, in the number of Warrant  Shares  purchasable  at such price upon exercise,
setting forth in reasonable  detail the method of calculation and the facts upon
which such calculation is based.

                                       6
<PAGE>

     (f)  Adjustment  in  Number of  Securities.  Upon  each  adjustment  of the
Exercise  Price  pursuant  to the  provisions  of this  Section 5, the number of
securities  issuable  upon the exercise of each Warrant shall be adjusted to the
nearest  full amount by  multiplying  a number  equal to the  Exercise  Price in
effect  immediately  prior to such  adjustment  by the number of Warrant  Shares
issuable upon exercise of the Warrants  immediately prior to such adjustment and
dividing the product so obtained by the adjusted Exercise Price.

     (g)  Definition  of Stock.  For the  purpose  of this  Agreement,  the term
"Stock"  shall  mean (i) the class of stock  designated  as Common  Stock in the
Certificate  of  Incorporation  of the  Company as may be amended as of the date
hereof,  or (ii) any other class of stock resulting from  successive  changes or
reclassifications  of such Stock  consisting  solely of changes in par value, or
from par value to no par value, or from no par value to par value.

     (h) No Adjustment of Exercise Price in Certain Cases.  No adjustment of the
Exercise Price shall be made:

     (i) Upon issuance or sale of this Warrant or Warrant  Shares,  or the other
Warrants and Warrant  Shares issued in connection  herewith,  or other  options,
warrants and  convertible  securities  outstanding as of the date hereof into or
for shares of Common Stock.

     (ii) Upon the issuance or sale of any shares of capital stock, or the grant
of  options  exercisable  therefor,  issued or  issuable  after the date of this
Warrant,  to directors,  officers,  employees,  advisers and  consultants of the
Company or any  subsidiary  pursuant to any  incentive  or  non-qualified  stock
option plan or agreement,  stock purchase plan or agreement,  stock  restriction
agreement  or  restricted  stock plan,  employee  stock  ownership  plan (ESOP),
consulting  agreement,  stock appreciation right (SAR), stock depreciation right
(SDR),  bonus stock  arrangement,  or such other similar  compensatory  options,
issuances, arrangements, agreements or plans approved by the Board of Directors.

     (iii) If the amount of said adjustment  shall be less than one cent ($0.01)
per security issuable upon exercise of this Warrant, provided,  however, that in
such case any adjustment  that would otherwise be required then to be made shall
be carried  forward and shall be made at the time of and together  with the next
subsequent  adjustment  which,  together with any adjustment so carried forward,
shall amount to at least two cents  ($0.02) per security  issuable upon exercise
of this Warrant.

     6. No  Impairment.  The Company  will not, by  amendment  of its charter or
through reorganization,  consolidation,  merger, dissolution,  sale of assets or
any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this  Warrant  but will at all  times  carry out all such
terms and take all such action as may be reasonably  necessary or appropriate in
order to protect the rights of the holder of this Warrant against impairment.

     7.  Liquidating  Dividends and Other  Distributions.  If the Company pays a
dividend or makes a distribution  on the Common Stock payable  otherwise than in
cash out of earnings or earned surplus  (determined in accordance with generally
accepted accounting principles) except for a stock dividend payable in shares of
Common  Stock  (a  "Liquidating  Dividend")  or  otherwise  distributes  to  its

                                       7
<PAGE>

stockholders  any  assets,   properties,   rights,   evidence  of  indebtedness,
securities  whether  issued by the Company or by another,  or any other thing of
value,  then the Company will pay or distribute to the Registered Holder of this
Warrant,  upon the exercise hereof,  in addition to the Warrant Shares purchased
upon such  exercise,  either (i) the  Liquidating  Dividend that would have been
paid to such  Registered  Holder  if he had been the  owner  of  record  of such
Warrant Shares immediately prior to the date on which a record is taken for such
Liquidating  Dividend or, if no record is taken, the date as of which the record
holders of Common Stock  entitled to such  dividends or  distribution  are to be
determined or (ii) the same property, assets, rights, evidences of indebtedness,
securities  or any other thing of value that the  Registered  Holder  would have
been entitled to receive at the time of such  distribution as if the Warrant had
been exercised immediately prior to such distribution.

     8. Notices of Record Date, Etc. In case:

     (a) the Company  shall take a record of the holders of its Common Stock (or
other stock or  securities  at the time  deliverable  upon the  exercise of this
Warrant) for the purpose of  entitling or enabling  them to receive any dividend
or other distribution,  or to receive any right to subscribe for or purchase any
shares of stock of any class or any other  securities,  or to receive  any other
right; or of any capital  reorganization of the Company, any reclassification of
the capital  stock of the Company,  any  consolidation  or merger of the Company
with or into another  corporation (other than a consolidation or merger in which
the Company is the surviving  entity),  or any transfer of all or  substantially
all  of  the  assets  of  the  Company;  or  of  the  voluntary  or  involuntary
dissolution,  liquidation  or winding-up of the Company,  then, and in each such
case,  the Company will mail or cause to be mailed to the  Registered  Holder of
this  Warrant a notice  specifying,  as the case may be, (i) the date on which a
record is to be taken for the purpose of such dividend,  distribution  or right,
and stating the amount and character of such dividend, distribution or right, or
(ii)  the  effective  date  on  which  such  reorganization,   reclassification,
consolidation,  merger, transfer,  dissolution,  liquidation or winding-up is to
take  place,  and the time,  if any is to be fixed,  as of which the  holders of
record  of  Common  Stock  (or  such  other  stock  or  securities  at the  time
deliverable  upon the  exercise of this  Warrant)  shall be entitled to exchange
their shares of Common Stock (or such other stock or securities)  for securities
or  other  property  deliverable  upon  such  reorganization,  reclassification,
consolidation,  merger, transfer,  dissolution,  liquidation or winding-up. Such
notice  shall be  mailed  at least ten (10)  days  prior to the  record  date or
effective  date for the event  specified in such notice unless such prior notice
is waived by the Registered Holder.

     9. No Rights of  Stockholders.  Subject to other  Sections of this Warrant,
the  Registered  Holder shall not be entitled to vote,  to receive  dividends or
subscription  rights, nor shall anything contained herein be construed to confer
upon the Registered  Holder,  as such, any of the rights of a stockholder of the
Company,  including  without  limitation  any right to vote for the  election of
directors  or upon any matter  submitted  to  stockholders,  to give or withhold
consent to any corporate action (whether upon any recapitalization,  issuance of
stock,  reclassification  of stock, change of par value or change of stock to no
par value, consolidation, merger, conveyance, or otherwise), to receive notices,
or otherwise, until the Warrant shall have been exercised as provided herein.

                                       8
<PAGE>

     10.  Registration  Rights.  The Registered  Holder shall be entitled to the
registration  rights set forth in the  registration  rights agreement as of even
date herewith that is being executed in connection with the Securities  Purchase
Agreement.

     11.   Replacement   of  Warrant.   Upon  receipt  of  evidence   reasonably
satisfactory  to the Company of the loss,  theft,  destruction  or mutilation of
this Warrant and (in the case of loss, theft or destruction) upon delivery of an
indemnity agreement  reasonably  satisfactory to the Company, or (in the case of
mutilation)  upon surrender and  cancellation of this Warrant,  the Company will
issue, in lieu thereof, a new Warrant of like tenor.

     12. Mailing of Notices,  Etc. All notices and other communications from the
Company to the Registered  Holder of this Warrant shall be mailed by first-class
certified or registered mail,  postage prepaid,  to the address furnished to the
Company in writing by the last Registered  Holder of this Warrant who shall have
furnished  an  address  to  the  Company  in  writing.  All  notices  and  other
communications  from the  Registered  Holder of this  Warrant  or in  connection
herewith to the Company shall be mailed by  first-class  certified or registered
mail,  postage prepaid,  to the Company at its principal office set forth below.
If the Company should at any time change the location of its principal office to
a place other than as set forth below,  then it shall give prompt written notice
to the  Registered  Holder of this Warrant and thereafter all references in this
Warrant to the location of its principal  office at the particular time shall be
as so specified in such notice.

     13.  Change or Waiver.  Any term of this  Warrant  may be changed or waived
only by an instrument in writing  signed by the party against which  enforcement
of the change or waiver is sought.

     14.  Headings.  The  headings in this Warrant are for purposes of reference
only and shall not limit or  otherwise  affect the meaning of any  provision  of
this Warrant.

     15.  Severability.  If any  provision of this  Warrant  shall be held to be
invalid and unenforceable,  such invalidity or unenforceability shall not affect
any other provision of this Warrant.

     16.  Governing  Law and  Submission to  Jurisdiction.  This Warrant will be
governed by and construed in  accordance  with the laws of the State of New York
without regard to principles of conflict or choice of laws of any  jurisdiction.
The parties hereby agree that any action, proceeding or claim against it arising
out of, or relating in any way to this Warrant  shall be brought and enforced in
the  courts  of  the  State  of  New  York,  and  irrevocably   submit  to  such
jurisdiction, which jurisdiction shall be exclusive.

     17. Certificate. Upon request by the Registered Holder of this Warrant, the
Company  shall  promptly  deliver to such holder a  certificate  executed by its
President  or  Chief  Financial  Officer  setting  forth  the  total  number  of
outstanding  shares of capital stock,  convertible debt instruments and options,
rights,  warrants or other  agreements  relating to the purchase of such capital
stock or  convertible  debt  instruments,  together with its  calculation of the

                                       9
<PAGE>

number of shares remaining available for issuance upon exercise of this Warrant,
and a certificate of the accuracy of the statements set forth therein.

     18.  Supplements and Amendments.  The Company and the Registered Holder may
from  time to time  supplement  or  amend  this  Warrant  in  order  to cure any
ambiguity,  to correct or supplement any provision contained herein which may be
defective  or  inconsistent  with any  provision  herein,  or to make any  other
provisions in regard to matters or questions arising hereunder which the Company
and the Holder may deem necessary or desirable.

     19.  Successors.  All the covenants and provisions of this Warrant shall be
binding upon and inure to the benefit of the Company and the  Registered  Holder
and their respective successors and assigns hereunder.

     20. Benefits of this Warrant. Nothing in this Warrant shall be construed to
give to any  person,  entity  or  corporation  other  than the  Company  and the
Registered  Holder of the  Warrant  Certificate  any legal or  equitable  right,
remedy or claim under this  Warrant;  and this Warrant shall be for the sole and
exclusive  benefit  of the  Company  and the  Registered  Holder of the  Warrant
Certificate.

     21.   Counterparts.   This  Warrant  may  be  executed  in  any  number  of
counterparts and each such counterpart shall for all purposes be deemed to be an
original,  and such counterparts shall together  constitute but one and the same
instrument.

                    Balance of Page Intentionally left Blank
                             Signature Page Follows

                                       10
<PAGE>

IN WITNESS WHEREOF, NESCO INDUSTRIES,  INC. has caused this Warrant to be signed
by its duly authorized  officers under its corporate seal and to be dated on the
day and year first written above.

                                NESCO INDUSTRIES, INC.

                                By:_________________________________
                                        Name: Matthew L. Harriton
                                        Title: President

                                Principal Office:  305 Madison Avenue,
                                                   Suite 4510
                                                   New York, NY 10165

                                       11
<PAGE>

                                    ANNEX A

                            NOTICE OF EXERCISE FORM

To:                                                     Dated:

     The  undersigned,  pursuant  to the  provisions  set forth in the  attached
Warrant, hereby irrevocably elects to purchase shares of Common Stock covered by
such  Warrant and herewith  makes  payment of $_______ ,  representing  the full
purchase  price for shares at the exercise  price per share provided for in such
Warrant.

                                                Signature:

                                                Address:

                                       12

<PAGE>

                                    ANNEX B

                                ASSIGNMENT FORM

     FOR VALUE RECEIVED, _________________________________ hereby sells, assigns
and transfers all of the rights of the  undersigned  under the attached  Warrant
with respect to the number of shares of Common Stock  covered  thereby set forth
below, unto:

Name of Assignee              Address                    No. of Shares

                                        Dated:

                                        Signature:

                                        Dated:

                                        Witness:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]